Outcome assessment in cardiac rehabilitation: Health-related quality of life and economic evaluation

Journal of Cardiopulmonary Rehabilitation

Volumn 17, Issue 3, 1997, Pages 179-194

  Oldridge, Neil B ^a  

^a UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARDIOVASCULAR DISEASE; HEALTH CARE COST; HEALTH ECONOMICS; HEART INFARCTION; HEART REHABILITATION; HUMAN; QUALITY OF LIFE;

COST-BENEFIT ANALYSIS; HEALTH SERVICES RESEARCH; HEART DISEASES; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); QUALITY OF LIFE; QUESTIONNAIRES; REHABILITATION; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN;

EID: 0030980401     PISSN: 08839212     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008483-199705000-00005     Document Type: Article

References (112)

1. Codman EA: The product of a hospital. Surg Gynecol Obstetr 1914;18:491-496.
2. Donabedian A: Evaluating the quality of medical care [Part 2]. Milbank Q 1966;44:166-206.
3. U.S. Department of Health and Human Services: Health, United States 1994. Hyattsville, MD: Public Health Service. DHHS Pub # (PHS) 1995;95-1232.
4. Eddy DM, Billings J: The quality of medical evidence: implications for quality of care. Health Affairs 1988;Spring:19-32.
5. Ellwood PM: Shattuck lecture: Outcomes management. N Engl J Med 1988;318:1549-1556.
6. Office of Technology Assessment: Identifying Health Technologies That Work: Searching for Evidence. OTA-H-608. Washington, DC: U.S. Government Printing Office, 1994.
7. U.S. Department of Health and Human Services: Research Plan for the National Center for Medical Rehabilitation Research. Rockville, MD: U. S. Department of Health and Human Services, National Institutes of Health, 1993.
8. U.S. Department of Education: National Institute on Disability and Rehabilitation Research Program Directory Fiscal year 1995. Washington, DC: Office of Special Education and Rehabilitation Services, 1995.
9. Pew Health Professions Commission: Critical Challenges: Revitalizing the Health Professions for the Twenty-First Century. San Francisco: UCSF Center for the Health Professions, 1995.
10. U.S. Department of Health and Human Services: Report of the National Commission on Allied Health. Rockville, MD: U. S. Department of Health and Human Services, Public Health Service, 1995.
11. World Health Organization: Constitution of the World Health Organization. Basic Documents. Geneva: World Health Organization, 1948.
12. Patrick DL, Erickson P: Health Status and Health Policy. Quality of Life in Health Care Evaluation and Resource Allocation. New York: Oxford University Press, 1993.
13. Schipper H, Clinch J, Olweny CLM: Quality of life studies: Definitions and conceptual issues. In: Spilker B, ed. Quality of Life and Pharmacoeconomics in Clinical Trials, ed 2. Philadelphia: Lippincott-Raven, 1996:11-23.
14. Relman AS: Assessment and accountability. The third revolution in medical care. N Engl J Med 1988;319:1220-1222.
15. Drummond MF, Stoddart GL, Torrance GW: Methods for the Economic Evaluation of Health Care Programmes. Oxford: Oxford University Press, 1988.
16. World Health Organization Expert Committee. Rehabilitation of patients with cardiovascular disease. Technical Report Series #270. Geneva: World Health Organization, 1964.
17. Wenger NK, Froelicher ES, Smith LK, et al: Cardiac Rehabilitation. Clinical Practice Guideline #17. Rockville, MD: U.S. Dept of Health & Human Services, Public Health Service, Agency for Health Care Policy & Research and the National Heart, Blood & Lung Institute. AHCPR # 96-0672, 1995.
18. Oldridge N, Guyatt G, Jones N, et al: Effects on quality of life with comprehensive rehabilitation after acute myocardial infarction. Am J Cardiol 1991;67:1084-1089.
19. American Association of Cardiovascular and Pulmonary Rehabilitation Outcomes Committee: Outcome measurement in cardiac and pulmonary rehabilitation. J Cardpulm Rehabil 1995;15:394-405.
20. Bergner M, Bobbit RA, Carter WB, Gilson BS: The Sickness Impact Profile: Development and final revision of a health status measure. Med Care 1981;19:787-805.
21. Damiano AM: The Sickness Impact Profile. In: Spilker B, ed. Quality of Life and Pharmacoeconomics in Clinical Trials. Philadelphia: Lippincott-Raven, 1996:347-354.
22. The EuroQol Group: EuroQol - a new facility for the measurement of health-related quality of life. Health Policy 1990;16:199-208.
23. Kind P: The EuroQol Instrument: An index of health-related quality of life. In: Spilker B, ed. Quality of Life and Pharmacoeconomics in Clinical Trials. Philadelphia: Lippincott-Raven, 1996:191-201.
24. Ware JE, Jr, Sherbourne CD: The MOS 36-Item Short-Form Health Survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-483.
25. Ware JE, Jr: The SF-36 Health Survey. In: Spilker B, ed. Quality of Life and Pharmacoeconomics in Clinical Trials. Philadelphia: Lippincott-Raven, 1996:337-345.
26. Torrance G: Utility approach to measuring health-related quality of life. J Chron Dis 1987;40:593-600.
27. Bennett KJ, Torrance GW: Measuring health state preferences and utilities. Rating scale, time trade-off, and standard gamble techniques. In: Spilker B, ed. Quality of Life and Pharmacoeconomics in Clinical Trials. Philadelphia: Lippincott-Raven, 1996:253-265.
28. Feeny DH, Furlong WJ, Torrance GW: Health utilities index. In: Spilker B, ed. Quality of Life and Pharmacoeconomics in Clinical Trials. Philadelphia: Lippincott-Raven, 1996:239-252.
29. Rector TS, Kubo SH, Cohn JN: Patients' self-assessment of their congestive heart failure: Content, reliability, and validity of a new measure, the Minnesota Living with Heart Failure Questionnaire. Heart Failure 1987;3:198-209.
30. Rector RS, Kubo SH, Cohn J: Validity of the Minnesota Living with Heart Failure Questionnaire as a measure of therapeutic response to Enalapril or placebo. Am J Cardiol 1993;71:1106-1107.
31. Spertus JA, Winder JA, Dewhurst TA, Deyo RA, Fihn SD: Monitoring the quality of life in patients with coronary artery disease. Am J Cardiol 1994;74:1240-1244.
32. Spertus JA, Winder JA, Dewhurst TA, et al: Development and evaluation of the Seattle Angina Questionnaire: A new functional status measure for coronary artery disease. J Am Coll Cardiol 1995;25:333-341.
33. Hillers TK, Guyatt GH, Oldridge NB, et al: Quality of life after myocardial infarction. J Clin Epidemiol 1994;47:1287-1296.
34. Lim LL-Y, Valenti LA, Knapp JC, et al: A self-administered quality of life questionnaire after acute myocardial infarction. J Clin Epidemiol 1993;46:1249-1256.
35. Valenti L, Lim L, Heller RF, Knapp J. An improved questionnaire for assessing quality of life after myocardial infarction. Qual Life Res 1996;5:151-161.
36. Avis NE, Smith KW, Hambleton RK, Feldman HA, Selwyn A, Jacobs A: Development of the Multidimensional Index of Quality of Life. A quality of life measure for cardiovascular disease. Med Care 1996;34:1102-1120.
37. Lim LL-Y, Johnson NA, O'Connell RL, Heller RF: Does quality of life predict death and later hospitalization in patients with suspected heart attack? Br Med J (submitted).
38. Guyatt GH, Walter S, Norman G:. Measuring change over time: Assessing the usefulness of evaluative instruments. J Chronic Dis 1987;40:171-178.
39. Guyatt GH, Deyo RA, Charlson M, Levine MN, Mitchell A: Responsiveness and validity in health status measures: A clarification. J Clin Epidemiol 1989;42:403-408.
40. Jaeschke R, Singer J, Guyatt GH: Ascertaining the minimal clinically important difference. Cont Clin Trials 1989;10:407-415.
41. Juniper EJ, Guyatt GH, Willan A, Griffith LE: Determining a minimally important change in a disease-specific quality of life questionnaire. J Clin Epidemiol 1994;4:81-87.
42. Kubo SH, Rector TS, Strobeck JE, Cohn JN: OPC-8212 in the treatment of congestive heart failure: Results of a pilot study. Cardiovas Drugs 1988;2:653-660.
43. Kubo SH, Gollub S, Bourge R, et al: Beneficial effects of pimobendan on exercise tolerance and quality of life in patients with heart failure. Circulation 1992;85:942-949.
44. Rector TS, Cohn JN: Assessment of patient outcome with the Minnesota Living with Heart Failur questionnaire: Reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Am Heart J 1992;124:1017-1025.
45. Rector TS, Johnson G, Dunkman WB, Daniels G, Farrell L, Hendrick A: Evaluation by patients with heart failure of the effects of enalapril compared with hydralizine plus isosorbide dinitrate on quality of life. V-HeFT II. Circulation 1993;87(SupplVI):VI-71-VI-77.
46. Wiklund I, Lindvall K, Swedberg K, Zupkis R: Self-assessment of quality of life in severe heart failure. Scan J Psychol 1987;28:220-225.
47. Feinstein AR, Fisher MB, Pigeon JG: Changes in dyspnea-fatigue ratings as indicators of quality of life in the treatment of congestive heart failure. Am J Cardiol 1989;64:50-55.
48. Guyatt GH, Nogradi S, Halcrow S, Singer J, Sullivan MJ, Fallen EL: Development and testing of a new measure of health status for clinical trials in heart failure. J Gen Intern Med 1989;4:101-107.
49. Guyatt GH: Measurement of health-related quality of life in heart failure. J Am Coll Cardiol 1993;72(Suppl A):185A-191A.
50. Guyatt G, Crowe J, McKelvie R, Runions J, Oldridge N: Assessing quality of life in cardiovascular disease: A general approach and an example in patients with myocardial infarction. Qual Life Cardiovasc Care 1986;2:304-310;317-318.
51. Oldridge NB, Gottlieb M, Guyatt GH, Jones NL, Feeny D, Streiner D: Predictors of health-related quality of life with cardiac rehabilitation after acute myocardial infarction. Am J Cardiol (in press).
52. Ebbesen L, McCartney N, Guyatt GH, Oldridge NB: Measuring quality of life in cardiac spouses. J Clin Epidemiol 1990;43:481-487.
53. Heller RF, Knapp JC, Valenti LA, Dobson AJ: Secondary prevention after acute myocardial infarction. Am J Cardiol 1993;72:759-762.
54. Heller RF, Lim L, Valenti L, Knapp J: A randomised controlled trial of community based counselling among those discharged from hospital with ischaemic heart disease. Aust NZ Med J 1995;25:362-364.
55. Kinney MR, Burfitt SN, Stullenbarger E, Rees B, DeBolt MR: Quality of life in cardiac patient research: A meta-analysis. Nurs Res 1996;45:173-180.
56. Chen AY, Daley J, Thibault GE: Angina patients' ratings of current health and health without angina: Associations with severity of angina and comorbidity. Med Decis Making 1996;16:169-177.
57. Krumholz HM, McHorney CA, Clark L, Levesque M, Baim DS, Goldman L: Changes in health after elective percutaneous coronary revascularization. A comparison of generic and specific measures. Med Care 1996;34:754-759.
58. Lyons RA, Lo SV, Littlepage BNC: Comparative health status of patients with 11 common illnesses in Wales. J Epidemiol Community Health 1994;48:388-390.
59. Ware JE, Jr, Bayliss MS, Rogers WH, Kosinski M, Tarlov AR: Differences in 4-year health outcomes for elderly and poor, chronically ill patients treated in HMO and fee-for-service systems. Results from the Medical Outcome Study. JAMA 1996;276:1039-1047.
60. Wiklund I, Karlson BW, Bengtson A, Herlitz J: Subjective symptoms and well-being one year after acute myocardial infarction in relation to age. Cardiol Elderly 1993;1:523-529.
61. O'Brien BJ, Buxton MJ, Patterson DL: Relationship between functional status and health-related quality-of-life after myocardial infarction. Med Care 1993;31:950-955.
62. Tsevat J, Goldman L, Lamas GA, et al: Functional status versus utilities in survivors of myocardial infarction. Med Care 1991;29:1153-1159.
63. Fryback DG, Dasbach J, Klein R, et al: The Beaver Dam Health Outcomes Study: Initial catalog of health-state quality factors. Med Decis Making 1993;13:89-102.
64. Tsevat J, Goldman L, Soukup JR, et al: Stability of time trade-off utilities in survivors of myocardial infarction. Med Decis Making 1993;13:161-165.
65. Wiklund I, Gorkin L, Pawitan Y, et al: Methods for assessing quality of life in the Cardiac Arrythmia Suppression Trial [CAST]. Qual Life Res 1992;1:187-201.
66. Rogers WJ, Johnstone DE, Yusuf S, et al: Quality of life among 5,025 patients with left ventricular dysfunction randomized between placebo and enalapril: The studies of left ventricular dysfunction. J Am Coll Cardiol 1994;23:393-400.
67. Cornell CE, Raczynski JM, Oberman A: Quality of life after coronary revascularization procedures. In: Spilker B, ed. Quality of Life and Pharmacoeconomics in Clinical Trials. Philadelphia: Lippincott-Raven, 1996:865-882.
68. Ferrans CE, Powers MJ: Quality of Life Index; Developmental and psychometric properties. Ad Nurs Science 1985;8:15-24.
69. Ferrans CE, Powers MJ: Psychometric assessment of the Quality of Life Index. Res Nurs Health 1985;15:29-38.
70. Daumer R, Miller P: Effects of cardiac rehabilitation on psychosocial functioning and life satisfaction of coronary artery disease clients. Rehabil Nurs 1992;17:69-72.
71. Deshotels A, Planchock N, Dech Z, Prevost S: Gender differences in perceptions of quality of life in cardiac rehabilitation patients. J Cardpulm Rehabil 1995;15:143-148.
72. Bliley AV, Ferran CE: Quality of life after coronary angioplasty. Heart Lung 1993;22:193-199.
73. Oldridge N: Health-related quality of life and economic evaluation of cardiac rehabilitation. In: Leon A, ed. Physical Activity and Cardiovascular Health. Champaign, Illinois: Human Kinetics, 1997; 183-190.
74. National Institutes of Health Development on Physical Activity and Cardiovascular Health. NIH Consensus Conference: Physical activity and cardiovascular health. JAMA 1996;276:241-246.
75. Shephard RJ, Kavanagh T, Klavora P: Mood state during postcoronary cardiac rehabilitation. J Cardpulm Rehabil 1985;5:480-484.
76. Blumenthal JA, Emery CF, Rejeski WJ: The effects of exercise training on psychosocial functioning after myocardial infarction. J Cardpulm Rehabil 1988;8:183-193.
77. Ott CR, Sivarajan ES, Newton KM, et al: A controlled randomized study of early cardiac rehabilitation: The Sickness Impact Profile as an assessment. Heart Lung 1983;12:162-170.
78. Jette DU, Downing J: Health status of individuals entering a cardiac rehabilitation program as measured by the Medical Outcomes Study 36-item SHort Form Survey (SF-36). Phys Ther 1994;74:521-527.
79. Lavie CJ, Milani RV: Effects of cardiac rehabilitation and exercise training on exercise capacity, coronary risk factors, behavioral characteristics, and quality of life in women. Am J Cardiol 1995;75:340-343.
80. Lavie CJ, Milani RV: Effects of cardiac rehabilitation programs on exercise capacity, coronary risk factors, behavioral characteristics, and quality of life in a large elderly cohort. Am J Cardiol 1995;76:177-179.
81. Jette DU, Downing J: The relationship of cardiovascular and psychological impairments to the health status of patients enrolled in cardiac rehabilitation programs. Phys Ther 1996;76:130-139.
82. Milani RV, Lavie CJ: Behaviorial differences and effects of cardiac rehabilitation in diabetic patients following cardiac rehabilitation. Am J Med 1996;100:517-523.
83. Worcester M, Hare D, Oliver R, Reid M, Goble A: Early programme of high and low intensity exercise and quality of life after myocardial infarction. Br Med J 1993;307:1244-1247.
84. Foster C, Oldridge NB, Dion W, et al: Time course of recovery during cardiac rehabilitation. J Cardpulm Rehabil 1995; 15:209-215.
85. Wennberg JE: AHCPR and the strategy for health care reform. Health Affairs 1992;11[Winter]:67-71.
86. Oregon Health Services Commission: Prioritization of Health services: A Report to the Governor and Legislature. Salem: Oregon Health Services Commission, 1991.
87. Tengs TO, Meyer G, Siegel JE, Pliskin JS, Graham JD, Weinstein MC: Oregon's medicaid ranking and cost-effectiveness: Is there any relationship? Med Decis Making 1996;16:99-107.
88. Canadian Coordinating Office for Health Technology Assessment: Guidelines for the Economic Evaluation of Pharmaceuticals: Canada, ed 1. Ottawa: CCHOTA, 1994.
89. Commonwealth of Australia: Background document on the use of economic evaluation as a basis for the inclusion of pharmaceutical products on the Pharmaceutical Benefits Scheme. Canberra: Australian Government Publishing Service, 1993.
90. Oldridge N, Furlong W, Feeny D, et al: Economic evaluation of cardiac rehabilitation soon after acute myocardial infarction. Am J Cardiol 1993;72:154-161.
91. Levin L-A, Perk J, Hedback B: Cardiac rehabilitation - cost analysis. J Intern Med 1991;230:427-434.
92. Bondestam E, Breikks A, Hartford M: Effects of early rehabilitation on consumption of medical care during the first year after acute myocardial infarction in patients ≥65 years of age. Am J Cardiol 1995;75:767-771.
93. Ades PA, Huang D, Weaver SO: Cardiac rehabilitation participation predicts lower rehospitalization costs. Am Heart J 1992;123:916-921.
94. Edwards WW, Glickman-Weiss E, Franks BD, lyriboz Y, Dodd SL, Quaid TP: Percutaneous transluminal coronary angioplasty rehabilitation. A cost-effectiveness analysis. J Cardpulm Rehabil 1993;13: 172-181.
95. Allison TG, Williams DE, Miller TD, et al: Medical and economic costs of psychologic distress in patients with coronary artery disease. Mayo Clin Proc 1995;70:734-742.
96. Dennis CA, Houston-Miller N, Schwartz RG, et al. Early return to work after uncomplicated myocardial infarction: Results of a randomized trial. JAMA 1988;260:214-220.
97. Picard MH, Dennis C, Schwartz RG, et al: Cost-benefit analysis of early return to work after uncomplicated acute myocardial infarction. Am J Cardiol 1989;63:1308-1314.
98. Pilote L, Thomas RJ, Dennis C, et al: Return to work after uncomplicated myocardial infarction: A trial of practice guidelines in the community. Ann Item Med 1992;117:383-389.
99. Ades PA: Decreased medical costs after cardiac rehabilitation. Acase for universal reimbursement. J Cardpulm Rehabil 1993;13:75-77.
100. Chua TP, Lipkin DP: Cardiac rehabilitation: Should be available to all who would benefit. Br Med J 1993;306:731-732.
101. Oldridge NB: Universal access and insurance coverage: Missing pieces. J Cardpulm Rehabil 1995;15:9-13.
102. Oldridge NB, Guyatt GH, Fischer M, Rimm AR: Cardiac rehabilitation after myocardial infarction: Combining data from randomized clinical trials. JAMA 1988;260:945-980.
103. O'Connor GT, Buring JE, Yusuf S, et al: An overview of randomized trials of rehabilitation with exercise after myocardial infarction. Circulation 1989;80:234-244.
104. Hedback B, Perk J: Five-year results of a comprehensive rehabilitation programme on mortality, morbidity and risk factors. Eur Heart J 1987;8:234-242.
105. Goldman L, Garber AM, Grover SA, Hlatky MA: Cost effectiveness of assessment and management of risk factors. J Am Coll Cardiol 1996;27:1020-1030.
106. Kupersmith J, Holmes-Rovner M, Hogan A, Rovner D, Gardiner J: Cost-effectiveness analysis in heart-disease, Part III: Ischemia, congestive heart failure, and arrythmias. Prog Cardiovasc Dis 1994;37:307-346.
107. Goldman L: Cost and quality of life: Thrombolysis and primary angioplasty. J Am Coll Cardiol 1995;25(Suppl):38S-41S.
108. Engblom E, Ronnemaa T, Hamalainen H, Kallio V, Vantinnen E, Knuts LR: Coronary heart disease risk factors before and after by-pass surgery: Results of a controlled trial on multifactorial rehabilitation. Eur Heart J 1992;13:232-237.
109. Oldridge NB, Hoffman R, Guyatt GH, Streiner D: Profile of mood states and cardiac rehabilitation after acute myocardial infarction. Med Sci Sport Exerc 1995;27:900-905.
110. Engblom E, Korpilahti K, Hamalainen H, Puukka P, Ronnemaa T: Effects of five years of cardiac rehabilitation after coronary artery bypass grafting on coronary risk factors. Am J Cardiol 1996;78:1428-1431.
111. DeBusk RF, Miller NH, Superko HR, et al: A case-management system for coronary risk factor modification after acute myocardial infarction. Ann Intern Med 1994;120:721-729.
112. Merz CNB, Rozanski A: Remodeling cardiac rehabilitation into secondary prevention programs. Am Heart J 1996;132:418-427.